All News

Several big pharma companies have added their names to a letter challenging suppliers in the healthcare industry to pledge to sustainability targets. 

The pharmaceutical supply chain has encountered numerous disruptions in the last few years, impacting procurement, manufacturing, packaging, and distribution operations within the pharmaceutical industry. Read about the rise in calls for near/resh...

Results from the TRAILBLAZER-ALZ 2 Randomised Clinical Trial into the use of donanemab to treat early symptoms of Alzheimer’s disease have been analysed. 

A quarterly series of articles about responsible supply chain management from the PSCI. 

Ardena and RiboPro have formed an alliance to boost their respective skills in manufacturing and producing nanoparticle and mRNA-based therapeutics to improve accessibility to this technology in the biotherapeutic landscape. 

In our new monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. 

Samsung Biologics agrees to use their biocampus Plant 4 for the manufacture of a line of products from Pfizer. 

Several biosimilars to AbbVie’s monoclonal antibody therapeutic Humira were launched by various pharmaceutical giants this week in the US, with more expected to be released by the end of the year as the patent expires.

In the USA, President Joe Biden will be signing an executive order to expand access to contraception. 

Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre...

Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients.

Throughout CPHI North America (Philadelphia, PA; April 25–27, 2023), we caught up with some of the exhibiting organisations to ask what the show brings to the North American pharmaceutical sector, and what is driving industry innovation in this r...

Novartis signs agreement with MPP to have generics of it's leukemia drug made so that it can be more easily distributed to the world's poorer countries. 

In our new monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond.  

Considering a recent Phase II trial, the FDA have granted accelerated approval to Roche and Genentech for their bispecfic therapeutic for the treatment of types of lymphoma. 

Since the onset of the COVID-19 pandemic, the innovative potential of mRNA vaccines and therapeutics has raised questions regarding their manufacturing, packaging, and storage/transportation. Learn about how the pharmaceutical supply chain is meet...

A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. 

Provision of healthcare is an important aspect of people's lives, especially those in the LGBTQIA+ community. Pharmaceutical companies are working to improve this access to medicine and representation for the population. 

Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute. 

The latest soft capsule technology from Roquette using modified pea starch as an alternative to gelatin. 

Novo Nordisk will invest 15.9 billion Danish kroner into the expansion of their existing API manufacturing facility.

Download your FREE pharma marketing eBook to learn why it is so important for pharmaceutical marketeers to develop their digital content marketing strategies in order to establish their companies as thought leaders and industry experts. 

Novavax, developers behind the Matrix-M adjuvant, have entered into an agreement with the Bill and Melinda Gates Medical Research Institute to provide the adjuvant in preclinical vaccine research.

A new partnership has been formed this month between Quanticate, the global biometric clinical research organisation, and KPS Life, a global functional service provider offering clinical outsourcing solutions to biopharmaceutical and medical device and...

In this written panel discussion experts in manufacturing in the pharmaceutical supply chain comment on the manufacturing landscape, how sustainable practices are being incorporated more readily, the challenges associated with this and the overall adva...

Roche has announced their plans to divest from their legacy Genentech biologics manufacturing facility as part of a larger operations strategy after emailed letters were sent to facility employees informing them of the decision.

Pharmaceutical contract packaging organisations (CPOs) offer organisations broader expertise in pharma packaging, specialist skills, and flexibility with time, efficiency, and costings for pharmaceutical companies lacking in-house packaging expert...

Throughout CPHI North America (Philadelphia, PA; April 25–27, 2023), we caught up with some of the exhibiting organisations to ask what the show brings to the North American pharmaceutical sector, and what is driving industry innovation in this r...

Lexicon Pharmaceuticals aiming to commercialise their recently approved heart failure drug in June, after receiving approval from the US FDA based on significant findings from two Phase III trials. 

Digital Editor Lucy Chard goes through the bioconjugate journey in this latest podcast from the CPHI Podcast Series, from development to manufacturing, with two experts in the field from Abzena, Louise Duffy and Campbell Bunce. 

Alliance Healthcare UK aids in the camapign for support for the Medicines to Ukraine initiative, which aims to supply hospitals in the war-torn country with the vital medicines they need to treat casualties from the conflict. 

The life science service and instrument provider have opened their new Singapore-based steriles drug manufacturing facility with the goal of bringing increased development and manufacturing capabilities for critical medicines to the APAC region. 

Throughout CPHI North America (Philadelphia, PA; April 25–27, 2023), we caught up with some of the exhibiting organisations to ask what the show brings to the North American pharmaceutical sector, and what is driving industry innovation in this r...

AbbVie and Genmab recently received approval from the US FDA for their joint venture, the blood cancer therapy epcoritamab, sold under the brand name EPKINLY. 

Discover the trends affecting the pharmaceutical CPO market, when and why outsourcing may be an enticing option, and what is driving pharmaceutical companies and CDMOs to partner with outsourced packaging and drug delivery organisations. ...

Roche launches into a new agreement with Zion Pharma, a leading Chinese pharmaceutical company, to help develop and commercialise their flagship small molecule tyrosine kinase inhibitor, ZN-A-1041. 

Recipharm receives regulatory approval for the manufacture of a microbiome-based product for the prevention of Clostridioides difficile recurrent infection, under GenIbet Biopharmaceuticals and Seres Therapeutics. 

Funded by the Bill & Melinda Gates Foundation, the Virginia Commonwealth University-based research-related institute will use the grant to expand on its current capabilities of bringing lifesaving medications around the world, as well as working on 14 ...

The collaboration between the pharmaceutical giant and scientific technology provider will aim to bring rapid and localised services to areas around the globe that lack affordable advanced genomic testing for breast and lung cancer.

A newly developed search tool uses AI to understand patient needs and reccomend the best clinical trials for their treatment, whilst keeping physicians centered in the process to ensure the best care. 

Discover the range of organic mineral salts that serve as Active Pharmaceutical Ingredients available from Dr. Paul Lohmann®.  

Throughout CPHI North America 2023, several Breakfast Sessions were held to start the day off right with a complimentary breakfast and a networking and learning session for our attendees. With insightful presentations from industry experts and partners...

In this written panel discussion experts in the pharmaceutical packaging industry comment on the current state of sustainability in packaging, and what can be done to improve this in the future.

Throughout CPHI North America 2023, several Breakfast Sessions were held to start the day off right with a complimentary breakfast and a networking and learning session for our attendees. With insightful presentations from industry experts and partners...

The European Union’s pharmaceutical industry could face a serious change in operations after Brussels published a proposal for the revamping of certain laws governing the industry. 

In the April episode of the CPHI Podcast Series we have a focus on sustainability, where Digital Editor Lucy Chard finds out what it means to be a Chief Sustainability Officer in the pharmaceutical industry from Nic Hunt, Global Head of Sustainability ...

Biogen has announced that they have received approval from the US FDA for the amyotrophic lateral sclerosis (ALS) treatment, QALSODY™ (tofersen). This is the first approval of a treatment that targets a genetic cause of ALS. 

This year marks the 5th anniversary of CPHI North America regional events. To celebrate this remarkable achievement, the CPHI show team hosted The Art of Pharma Anniversary Ball at the illustrious Philadelphia Museum of Art, with a keynote speech from ...

Bormioli Pharma has been designing innovative packaging solutions for the pharmaceutical industry for 200 years; in this interview Andrea Sentimenti described how they keep current in today's pharmaceutical landscape and how they are implementing s...

Follow along for live updates from the Content team as we bring you the latest from CPHI North America 2023 - from session talks, panel discussions, interviews, and more, there's a lot to discover with CPHI Online at the Pennsylvania Convention Cen...

As we prepare for CPHI North America from April 25–27 in Philadelphia, USA, CPHI Online caught up with some of the track sponsors to discuss how the show connects vital players within the North American pharmaceutical landscape.   ...

In the latest episode of the CPHI Podcast Series, Digital Editor Lucy Chard spoke with Dominik Rocchi of Ursatec. 

Merck and XtalPi Inc. collaborate on an AI-powered technology platform to predict the crystal morphologies of diabetic medication metformin HCl, validated by wet-lab experiments conducted with Merck’s expertise, in a ‘digital-first’ a...

Meet with Seqens team members at CPHi, April 25-27, 2023 to learn how we have extended services to rapidly and sustainably advance drug development. VISIT CPHI Booth 441 

Bora Pharmaceuticals, the international cGMP CDMO producing specialised pharmaceutical products such as sterile and non-sterile ophthalmics and nasal sprays for clinical use, is partnering with Celltrion Asia Pacific, subsidiary of Celltrion Group Inc.

Discover how the pharmaceutical workforce has evolved past the pandemic, and the challenges faced by the pharma industry during a talent acquisition and retention crisis. 

As we prepare for CPHI North America from April 25–27 in Philadelphia, USA, CPHI Online caught up with some of the track sponsors to discuss how the show connects vital players within the North American pharmaceutical landscape. 

NextPharma has completed their acquisition of a Norway-based manufacturing site, specialising in chewable tablet technologies for calcium/vitamin D3 from pharmaceutical giant Takeda.

GSK has signed licensed agreements with three companies to manufacture generic versions of its preventative HIV medicine for distribution in lower-income countries but calls for increased transparency is putting pressure on the drugmaker. 

We interview the winners of the Pharmapack Europe Awards 2023, who were chosen by a jury, and each developed an innovative solution in the categories of Drug Delivery Innovation, Packaging Innovation, Sustainability Initiative, Eco-Design, and Patient-...

In collaboration with Thermo Fisher Scientific, UCSF has opened a new manufacturing site aimed at accelerating advanced cell and gene therapies for cancer, rare diseases, and other illnesses.

A quarterly series of blog posts about responsible supply chain management from the PSCI Chair, Ingrid Vande Velde.

GSK has voluntarily opened the intellectual property rights on it's long-acting injectable HIV preventative medicine to three companies, so that they can make generic versions that will be more accessible to less-developed countries. 

Samsung Biologics, the leading end-to-end CDMO, is set to start building a new plant based in North Korea, to expand its biomanufacturing capabilties. 

What does the rise of AI-powered chatbots such as ChatGPT and GPT-4 mean for pharma marketeers? 

Pharmapack 2023 showcased a number of sessions on the key topics in the industry, from conference sessions to workshops, presented by experts in the field. 

The Pharma industry is expected to reach $1.9Tn in revenue by 2027, increasing at a rate of 3-6% per year, according to IQVIA1, with some regions being driven by volume, and others by innovation. Growth in developed economies is projected to be slow, w...

Learn how to meet the demands of a modern industry with an integrated CDMO for tailor-made advanced Softgel technologies, and discover what our expansion into North America will mean for our production capacities and growth in our latest infographic.

Insulin prices have dropped in a stark play by the three biggest makers of the product, after calls from the top of the US government. 

The HM Treasury in the UK has announced that they will be awarding the Medicines and Healthcare Products Regulatory Agency (MHRA) with £10 million to expedite the generation of new medicines for UK patients. 

Pfizer makes a bold move in the acquisition of innovative cancer therapy biotechnology company Seagen, the move means the doubling of their pipeline of early-stage therapeutics and gaining four leading ADC therapies. 

At Pharmapack 2023 in Paris we debuted a new and improved Start-Up Hub. The Hub included several start-up companies we are looking to support and make the event more accessible. 

In this series of interviews, we speak to the teams behind the winning concepts at CPHI Pharma Awards 2022, which was held at CPHI Frankfurt, across the categories from digital innovation to CEO of the year. 

Pfizer makes a breakthrough in migraine treatment with the approval from the US FDA of its new drug Zavzpret™ (zavegepant) in the form of a nasal spray, which adds to their current portfolio of oral migraine prevention and treatment therapies.&nb...

An agreement signed between TricorBraun and BioBottles will give nutraceutical companies (and potentially pharmaceutical companies) in the US and Canada access to the industry’s first fully biodegradable packaging option.

Vetter (Ravensbury, Germany), the aseptic filling and packaging CDMO has signed up to the UN Global Compact Network. 

The March episode of the CPHI Podcast Series is dedicated to celebrating International Women's Day, followng the theme #EmbraceEquity in the context of women's health. 

The latest results from a Phase II clinial trial into Enhertu shows consistently promising results, with a durable response in patients with various HER2-expressing tumours. 

We interview the winners of the Pharmapack Europe Awards 2023, who were chosen by a jury, and each developed an innovative solution in the categories of Drug Delivery Innovation, Packaging Innovation, Sustainability Initiative, Eco-Design, and Patient-...

In an effort to protect against potential future global health emergencies, the government of the UK and Moderna have cemented a 10-year partnership for vaccine manufacturing and research.

This year at Pharmapack 2023 in Paris, France, the CPHI Online team interviewed several leading women in the pharmaceutical industry about what it means to be a woman working in this field.

Vaccines for RSV from GSK and Pfizer to be analysed by a panel of experts with a view to informing a decision from the US FDA on their approval. 

In this podcast Digital Editor Lucy Chard is joined by Rachel Smith of Parexel to discuss the challenges surrounding the development of medicines for rare disease patients. 

Capsules encompass one of the most popular solid oral dosage forms for pharmaceutical products, with the global empty capsule market predicted to rise to USD $3.7 billion by 2026. The growth in the capsule market can be partly attributed to the many op...

At Pharmapack 2023, the CPHI team interviewed several leading women in the pharmaceutical industry about what it means to be a woman working in this field. Ahead of International Women’s Day on March 8, 2023, we are proud to provide a p...

Pharmapack 2023 showcased a number of sessions on the key topics in the industry, from conference sessions to workshops, presented by experts in the field. 

This year at Pharmapack 2023, we interviewed several leading women in the pharmaceutical industry about what it means to be a woman working in pharma. In the lead-up to International Women’s Day on March 8, 2023, CPHI Online is proud to highlight...

The US FDA are hoping to lead the way in addressing the lack of diversity and representation in clinical trials when developing medicines through new legislation. 

In an open letter to the European Commission, Medicines for Europe calls for a new medicine security contract with their goal to improve access to medicine and ensure a secure supply chain to Europe. 

We interview the winners of the Pharmapack Europe Awards 2023, which were held at Pharmapack in Paris. The winners, chosen by a jury, each developed an innovative solution in the categories of Drug Delivery Innovation, Packaging Innovation, Sustainabil...

With growing awareness for sustainable industry practices within pharmaceuticals, pharma packaging companies are facing pressures to balance drug efficacy, patient safety, supply chain security, and sustainability. Speakers Sriman Banerjee, Head of Pac...

We interview the winners of the Pharmapack Europe Awards 2023, which were held at Pharmapack in Paris. The winners, chosen by a jury, each developed an innovative solution in the categories of Drug Delivery Innovation, Packaging Innovation, Sustainabil...

West Pharmaceutical Services, Inc. speaks to CPHI Online about celebrating their 100-year anniversary as an industry leader, and how they plan to continue driving innovation after the challenges posed from global disruptions in the last few years.

Researchers have developed a computer model, that learns using AI, to identify potential drug compounds that can be used to block opioid receptors in the brain. 

At Pharmapack Europe 2023, we spoke to some of our exhibitors about the products they were showcasing at this year's event, and asked for their insights into the packaging market for the year ahead. 

As we continue to celebrate the contributions of women in the pharmaceutical field following International Day of Women and Girls in Science and in the lead up to International Women’s Day on March 8, 2023, we take a look at some of the historic ...

Pharmapack 2023 showcased a number of sessions on the key topics in the industry, from conference sessions to workshops, presented by experts in the field. 

Three reasons why advancing gender equity in healthcare should be a priority for pharma 

The US FDA have put a hold in place on the testing of an experimental breast cancer drug from Blueprint Medicines. 

In this series of interviews, we speak to the teams behind the winning concepts at CPHI Pharma Awards 2022, in each of the different categories, from digital innovation to CEO of the year. 

Insilico Medicine receives Orphan Drug Designation from the US FDA after successful Phase I clinical trial results for their AI-discovered drug INS018_055. 

Trodelvy, an antibody–drug conjugate with indications against certain types of cancer, has been approved by the US FDA for a third indication against pre-treated HR+/HER2- metastatic breast cancer.

An increasing number of drug development pipelines are turning towards the use of HPAPIs to target rare and ‘undruggable’ diseases. In this article, we talk to leading industry experts about how pharmaceutical manufacturers are adapting and...

We interview the winners of the Pharmapack Europe Awards 2023, which were held at Pharmapack in Paris. The winners, chosen by a jury, each developed an innovative solution in the categories of Drug Delivery Innovation, Packaging Innovation, Sustai...

Attending Pharmapack 2023 in Paris? Follow the live updates from the Content team as they move around the event, attending sessions, workshops, learning labs, and more from the Paris Expo. 

The Switzerland-based pharmaceutical process and ingredient developer and manufacturer announced the opening of their new sterile liquid drug product manufacturing facility in France.

We are pleased to announce the winners from the Pharmapack Europe Awards 2023 at this year's event in Paris. 

AMJEVITA, a biosimilar to Abbvie, Inc.’s Humira®, has been launched in the US by Amgen for the treatment of several inflammatory diseases, with the goal of both providing treatments to patients and reducing healthcare costs.

The annual report from Pharmapack 2023 covering the drug delivery market trends across Europe and the US, and how Pharmapack acts as a bridge between the global markets.

CPHI Online catches up with Pharmapack 2023 Premium Partner BD Medical to discuss how the pressures of a changing healthcare environment has demanded innovations within the pharmaceutical packaging sector. 

In this series of interviews, we speak to the teams behind the winning concepts at CPHI Pharma Awards 2022, in each of the different categories, from digital innovation to CEO of the year. 

The UK Medicines and Healthcare products Regulatory Agency have approved an innovative framework to enable seamless use of Point of Care products that will benefit patients. 

Apex Labs, a leader in psychedelic medicine, gains a No Objection Letter from Health Canada, meaning they can start recruiting for their latest trial. 

Ahead of Pharmapack 2023, we are featuring some of the start-up companies we are working closely with, and who will be attending the event held in Paris 1&2 Feb 2023. 

Eli Lilly's Alzheimer's drug donanemab is rejected for accelerated approval by the US FDA, but the clinical trial data still shows promise for coming up for standard approval later in the year. 

With the Lunar New Year ushering in celebrations for the pharmaceutical community around the world on Sunday January 22, 2023, we’ve rounded up some of the top CPHI Online articles and reports from the last year looking at pharmaceutical markets ...

An expansion of Pfizer’s not-for-profit health equity program will offer up to 500 patented and off-patent products to 45 lower-income countries, building on their initial offering of patented medicines and vaccines in the US and EU.

In this series of interviews, we speak to the teams behind the winning concepts at CPHI Pharma Awards 2022, in each of the different categories, from digital innovation to CEO of the year. 

A new HPAPI development and manufacturing block is now open at Sai Life Sciences’ Bidar Manufacturing Campus, expanding the CRDMO’s capabilities in small molecule discovery and commercialisation.

CPHI Online discusses the importance of sustainability considerations at this year’s Pharmapack with Sustainability Partner Stevanato Group, in anticipation of Pharmapack Europe taking place in Paris, France from February 1–2, 2023.